Efficacy of Pulmonary Surfactan in the Treatment of Infants with Acute Respiratory Distress Syndrome / 中国药房

OBJECTIVE:To evaluate the efficacy of pulmonary surfactan (PS) in the treatment of acute respiratory distress syndrome (ARDS) in infants after undergoing cardio-pulmonary bypass. METHODS: Twenty ADRS infants were randomly assigned to receive routine therapy alone (control group) or routine therapy in combination with PS (trial group). The clinical efficacy in two groups was monitored. RESULTS: In the trial group compared with the control group, the mortality rate was significantly lower(P